Aclarion
PublicCommercial-stage healthcare technology company leveraging biomarkers and proprietary AI algorithms to help physicians identify the source of chronic low back pain. Its Nociscan platform is the first evidence-supported SaaS tool to noninvasively distinguish between painful and nonpainful discs.
Founders Jeff Thramann
CEO Brent Ness
Company
Founded
2008
Headquarters
Broomfield, US
Employees
11-50
Financials
Total Funding
$17M
Public Market
Exchange
NASDAQ
Ticker
ACON
Funding History
2 rounds Undisclosed Jan 13, 2026
$10M Seed Jan 1, 2015
$7M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.